The impact of primary diseases is substantial, demanding advanced therapeutic options. Regenerative therapies represent a particularly exciting avenue, offering the potential to repair damaged parenchymal tissue and enhance clinical outcomes. Currently, research focuses on several approaches, including the delivery of adult regenerative units direc